These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21879887)

  • 21. Comparison of nonmydriatic digital retinal imaging versus dilated ophthalmic examination for nondiabetic eye disease in persons with diabetes.
    Chow SP; Aiello LM; Cavallerano JD; Katalinic P; Hock K; Tolson A; Kirby R; Bursell SE; Aiello LP
    Ophthalmology; 2006 May; 113(5):833-40. PubMed ID: 16650680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A double-blind study comparing 0.5% and 1% tropicamide for annual retinal screening in diabetic adolescents.
    Hassler-Hurst J; Wadham C; Rayman G
    Diabet Med; 2004 May; 21(5):434-9. PubMed ID: 15089787
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of acute angle-closure glaucoma after diagnostic mydriasis in nonselected subjects: the Rotterdam Study.
    Wolfs RC; Grobbee DE; Hofman A; de Jong PT
    Invest Ophthalmol Vis Sci; 1997 Nov; 38(12):2683-7. PubMed ID: 9375589
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for diabetic retinopathy by ophthalmologists and endocrinologists with pupillary dilation and a nonmydriatic digital camera.
    Deb-Joardar N; Germain N; Thuret G; Manoli P; Garcin AF; Millot L; Gavet Y; Estour B; Gain P
    Am J Ophthalmol; 2005 Nov; 140(5):814-821. PubMed ID: 16310458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-term mortality and retinopathy in type 1 diabetes.
    Grauslund J
    Acta Ophthalmol; 2010 May; 88 Thesis1():1-14. PubMed ID: 20500731
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized double-blind study of phenylephrine 2.5% vs 10% on pupillary dilation.
    Yospaiboon Y; Luanratanakorn P; Noppawinyoowong C
    J Med Assoc Thai; 2004 Nov; 87(11):1380-4. PubMed ID: 15825717
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for sight threatening diabetic retinopathy using non-mydriatic retinal camera in a primary care setting: to dilate or not to dilate?
    Baeza M; Orozco-Beltrán D; Gil-Guillen VF; Pedrera V; Ribera MC; Pertusa S; Merino J
    Int J Clin Pract; 2009 Mar; 63(3):433-8. PubMed ID: 19222628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pupil dilation using a standard cataract surgery regimen alone or with atropine 1.0% pretreatment: prospective comparative evaluation.
    Narváez J; Kronberg BP; Park H; Zumwalt JR; Wong B; Bacon G; Rauser M; Hoehn AS; Eiseman H; Zimmerman G
    J Cataract Refract Surg; 2010 Apr; 36(4):563-7. PubMed ID: 20362846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of the efficacy and safety of the ophthalmic insert Mydriasert in patients undergoing retinal angiography.
    Cagini C; Caricato A; Tosi G; Pascale A; Cesari C; Fiore T
    Eur J Ophthalmol; 2014; 24(5):728-34. PubMed ID: 24557758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The autonomic pupillary dysfunction in type II diabetes mellitus].
    Yang YB; Yu YB; Fu Q
    Zhonghua Yan Ke Za Zhi; 2006 Jul; 42(7):616-9. PubMed ID: 17081420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Redilatation with intracameral mydriatics in phacoemulsification surgery.
    Bäckström G; Behndig A
    Acta Ophthalmol Scand; 2006 Feb; 84(1):100-4. PubMed ID: 16445447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinopathy and macro-albuminuria in type 2 diabetic patients.
    Phoksunthorn T; Thatsnarong D
    J Med Assoc Thai; 2007 Apr; 90(4):684-7. PubMed ID: 17487122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effects of three madriatics on the human ocular aberrations].
    Yu J; Chen H; Hu JY; Xun PC
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):826-31. PubMed ID: 16191351
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?
    Haddad DE; Rosenfield M; Portello JK; Krumholz DM
    Ophthalmic Physiol Opt; 2007 May; 27(3):311-4. PubMed ID: 17470245
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of vibration perception threshold in type 2 diabetic patients with proliferative retinopathy.
    Magri CJ; Calleja N; Buhagiar G; Fava S; Vassallo J
    Postgrad Med J; 2011 Oct; 87(1032):658-63. PubMed ID: 21954032
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disorders of the blood-aqueous barrier after phacoemulsification in diabetic patients.
    Liu Y; Luo L; He M; Liu X
    Eye (Lond); 2004 Sep; 18(9):900-4. PubMed ID: 15017379
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of mydriatic efficacy of spray application and drop instillation of tropicamide 1%.
    Akman A; Aydin P
    Eye (Lond); 1999 Oct; 13 ( Pt 5)():653-5. PubMed ID: 10696320
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperhomocysteinemia in patients with diabetes mellitus with and without diabetic retinopathy.
    Goldstein M; Leibovitch I; Yeffimov I; Gavendo S; Sela BA; Loewenstein A
    Eye (Lond); 2004 May; 18(5):460-5. PubMed ID: 15131674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ocular autonomic nerve function in proliferative diabetic retinopathy.
    Clark CV
    Eye (Lond); 1988; 2 ( Pt 1)():96-101. PubMed ID: 3044851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diabetic retinopathy progression and visual outcome after phacoemulsification in South-Asian and Afro-Caribbean patients with diabetes.
    Chatterjee S; Savant VV; Stavrou P
    Eye (Lond); 2004 Jun; 18(6):575-9. PubMed ID: 14716320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.